Venture Capital Investors

H.I.G. Capital

H.I.G. Capital is a venture capital fund that funds tech companies.

Venture Investor Overview

Venture Investor
H.I.G. Capital
Status
InActive
Investor Type
Venture Capital
Activity Level
103 transactions
Funds Raised
At least $3.8 billion
Industry Focus
ECommerce
Enterprise IT
Medical Devices & Instruments

Contact Information

Contact
Tony Tamer
Title
Chief Executive Officer
Mailing Address
1 Sansome St. 37th Floor
San Francisco, CA 94104
USA
Phone
(415) 439-5500
Website
www.higventures.com
Email Address
Not Recorded

Background Information

Overview
H.I.G. is a leading private equity and venture capital investment firm with more than $3 Billion of equity capital under management. We have offices in Miami, Atlanta, Boston and San Francisco. We specialize in providing capital to small and medium-sized companies with attractive growth potential.
Profile
H.I.G. Capital LinkedIn Company Profile
Social Media
H.I.G. Capital Company Twitter Account
Company News
H.I.G. Capital News
Facebook
H.I.G. Capital on Facebook
YouTube
H.I.G. Capital on YouTube
Last Transaction
11/16/2023

Transaction History

Our records indicate that H.I.G. Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
OnTarget Laboratories
11/16/2023
$30,000,000
Augmedics
6/27/2023
$82,500,000
Invoca
6/14/2022
$83,000,000
Bolt Financial
1/25/2022
$355,000,000
Everlaw
11/3/2021
$202,000,000
Click Therapeutics
10/26/2021
$52,000,000
JumpCloud
10/20/2021
$225,000,000
JumpCloud
9/14/2021
$159,000,000
Suzy
7/29/2021
$50,000,000
Salary.com
4/30/2021
$67,000,000
ServiceTitan
3/30/2021
$500,000,000
Sitetracker
1/28/2021
$42,000,000
JumpCloud
1/13/2021
$25,000,000
Mode Analytics
8/7/2020
$33,000,000
Passport Digital
12/11/2019
$65,000,000
Clarify Medical
10/24/2019
$18,000,000
Invoca
10/18/2019
$56,000,000
Exagen Diagnostics
7/17/2019
$22,600,000
MX
6/26/2019
$100,000,000
Intact Vascular
5/30/2019
$25,000,000
Eruptr
10/5/2018
Unknown
Parachute
6/28/2018
$30,000,000
Neurana Pharmaceuticals
5/8/2018
$60,000,000
VertiFlex
3/9/2017
$40,000,000
AdTheorent
2/27/2017
Unknown
SCUF Gaming
2/7/2017
Unknown
Nutrinia
8/19/2016
$30,000,000
Iconic Therapeutics
8/10/2016
$10,000,000
Iconic Therapeutics
1/11/2016
$40,000,000
Go2mobi
9/17/2015
Unknown
Orbus Therapeutics
8/21/2015
$32,500,000
Calhoun Vision
6/30/2015
$68,999,900
NeuWave Medical
5/28/2015
$25,000,000
Intact Vascular
5/15/2015
$38,900,000
Boostability
10/18/2014
Unknown
Lulus
8/13/2014
Unknown
Iconic Therapeutics
4/16/2014
$20,000,000
ForSight VISION5
4/16/2014
$15,000,000
Cardeas Pharma
5/23/2013
$34,000,000
California Forensic Medical Group
3/31/2013
Unknown
Cerephex
12/31/2012
$5,924,000
Intact Vascular
9/6/2012
$15,500,000
Funambol
8/27/2012
$5,720,526
NeuWave Medical
8/6/2012
$14,000,000
Alder Biopharmaceuticals
4/19/2012
$38,000,000
Apollo Endosurgery
2/6/2012
$47,600,000
HyperBranch Medical Technology
12/31/2011
$1,036,000
Hart InterCivic
7/6/2011
Unknown
HyperBranch Medical Technology
12/31/2010
$2,072,000
SpotXchange
12/15/2010
$12,000,000
Nexidia
10/18/2010
$23,000,000
Higher Gear Group
6/30/2010
Unknown
NeurAxon
12/30/2009
$8,750,000
Triad Digital Media
12/5/2009
Unknown
Care Dynamix
9/9/2009
$7,000,000
Suniva
7/27/2009
$75,000,000
HyperBranch Medical Technology
6/30/2009
$1,167,000
Batanga
4/21/2009
$2,500,000
Clarus Therapeutics
3/31/2009
$5,086,900
Gemin X Pharmaceuticals
7/1/2008
$38,000,000
Zilker Labs
6/30/2008
$3,000,000
Funambol
6/17/2008
$12,500,000
Alder Biopharmaceuticals
1/11/2008
$40,000,000
REVShare
12/11/2007
$20,000,000
Clarus Therapeutics
11/27/2007
$8,000,000
Tranzyme Pharma
11/1/2007
$20,000,000
Metastatix
10/9/2007
$35,000,000
Apollo Endosurgery
10/8/2007
$11,500,000
Zilker Labs
10/2/2007
$10,000,000
CYA Technologies
8/23/2007
$3,000,000
NeurAxon
8/20/2007
$32,000,000
Batanga
8/13/2007
$30,000,000
EGT
6/26/2007
$5,000,000
Invistics
12/31/2006
$1,199,900
Elixir Pharmaceuticals
11/29/2006
$46,000,000
Lancope
11/27/2006
$1,600,000
FanLib
11/7/2006
$3,000,000
Ideal Image Development
9/20/2006
$16,000,000
Metastatix
9/7/2006
$3,600,000
iVivity
8/24/2006
$10,000,000
Nexidia
8/8/2006
$13,000,000
Alder Biopharmaceuticals
7/7/2006
$16,000,000
NorthStar Systems International
6/30/2006
$2,000,000
Zilker Labs
5/8/2006
$8,000,000
CardioFocus
4/24/2006
$21,500,000
Tranzyme Pharma
3/31/2006
$10,000,000
NorthStar Systems International
3/31/2006
$4,500,000
EGT
2/27/2006
$8,500,000
HexaTech
11/30/2005
$8,900,000
Funambol
8/9/2005
$5,000,000
Nexidia
6/30/2005
$5,500,000
Gemin X Pharmaceuticals
5/19/2005
$50,000,000
Tranzyme Pharma
5/13/2005
$32,000,000
Vocalocity
3/31/2005
$6,000,000
Netifice Communications
3/8/2005
$55,000,000
LVL7 Systems
2/9/2005
$21,000,000
HyperBranch Medical Technology
1/25/2005
$6,000,000
iVivity
6/3/2004
$26,000,000
NorthStar Systems International
6/2/2004
$11,500,000
Lancope
4/13/2004
$12,500,000
Inovys
2/18/2004
$16,300,000
VistaScape Security Systems
1/12/2004
$10,500,000
Lancope
3/11/2003
$5,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
John Black
  John Black LinkedIn Profile  John Black Twitter Account  John Black News  John Black on Facebook
Managing Director
Craig Burson
  Craig Burson LinkedIn Profile  Craig Burson Twitter Account  Craig Burson News  Craig Burson on Facebook
Managing Director
Matt Gullen
  Matt Gullen LinkedIn Profile  Matt Gullen Twitter Account  Matt Gullen News  Matt Gullen on Facebook
Principal
Evan Karp
  Evan Karp LinkedIn Profile  Evan Karp Twitter Account  Evan Karp News  Evan Karp on Facebook
Managing Director
John Kim
  John Kim LinkedIn Profile  John Kim Twitter Account  John Kim News  John Kim on Facebook
Managing Director
Steve Loose
  Steve Loose LinkedIn Profile  Steve Loose Twitter Account  Steve Loose News  Steve Loose on Facebook
Chief Executive Officer
Sami Mnaymneh
  Sami Mnaymneh LinkedIn Profile  Sami Mnaymneh Twitter Account  Sami Mnaymneh News  Sami Mnaymneh on Facebook
Managing Director
Nik Shah
  Nik Shah LinkedIn Profile  Nik Shah Twitter Account  Nik Shah News  Nik Shah on Facebook
Principal
Anish Sheth
  Anish Sheth LinkedIn Profile  Anish Sheth Twitter Account  Anish Sheth News  Anish Sheth on Facebook
Chief Executive Officer
Tony Tamer
  Tony Tamer LinkedIn Profile  Tony Tamer Twitter Account  Tony Tamer News  Tony Tamer on Facebook
Principal
Eric Tencer
  Eric Tencer LinkedIn Profile  Eric Tencer Twitter Account  Eric Tencer News  Eric Tencer on Facebook
Managing Director
Mark Tricolli
  Mark Tricolli LinkedIn Profile  Mark Tricolli Twitter Account  Mark Tricolli News  Mark Tricolli on Facebook

 

Funds

Our database includes the following fund closing(s) for H.I.G. Capital. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
H.I.G. Growth Buyouts & Equity Fund III
9/27/2018
$932,400,000
H.I.G. European Capital Partners II
7/2/2013
$1,100,000,000
H.I.G. Capital Partners V
3/5/2013
$1,000,000,000
H.I.G. BioVentures II
4/10/2012
$268,000,000
H.I.G. Growth Buyouts & Equity Fund II
6/27/2011
$500,000,000

 

Portfolio Companies

H.I.G. Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
AdTheorent
Alder Biopharmaceuticals
Apollo Endosurgery
Augmedics
Batanga
Bolt Financial
Boostability
Calhoun Vision
California Forensic Medical Group
Cardeas Pharma
CardioFocus
Care Dynamix
Cerephex
Clarify Medical
Clarus Therapeutics
Click Therapeutics
CYA Technologies
EGT
Elixir Pharmaceuticals
Eruptr
Everlaw
Exagen Diagnostics
FanLib
ForSight VISION5
Funambol
Gemin X Pharmaceuticals
Go2mobi
Hart InterCivic
HexaTech
Higher Gear Group
HyperBranch Medical Technology
Iconic Therapeutics
Ideal Image Development
Inovys
Intact Vascular
Invistics
Invoca
iVivity
JumpCloud
Lancope
Lulus
LVL7 Systems
Metastatix
Mode Analytics
MX
Netifice Communications
Neurana Pharmaceuticals
NeurAxon
NeuWave Medical
Nexidia
NorthStar Systems International
Nutrinia
OnTarget Laboratories
Orbus Therapeutics
Parachute
Passport Digital
REVShare
Salary.com
SCUF Gaming
ServiceTitan
Sitetracker
SpotXchange
Suniva
Suzy
Tranzyme Pharma
Triad Digital Media
VertiFlex
VistaScape Security Systems
Vocalocity
Zilker Labs

 

 

 

 

Browse more venture capital investors:

H.E.N.R.Y Collective Ventures | H.I.G. Growth Partners

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.